SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Norway Awards Lytix Biopharma NOK 12 Million for Tumor Research

The Research Council of Norway awarded Lytix Biopharma NOK 12 million to extend its oncolytic platform to deep-seated tumors.

Related stories